(Q43625313)

25 November 2017

title

Therapy of adult acute leukemia with daunorubicin and L-asparaginase (English)

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

30 January 2023

1 reference

1 reference

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

30 January 2023

author name string

Coltman CA Jr

3

1 reference

25 November 2017

G. P. Bodey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4521886

30 January 2023

J. S. Hewlett

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4521886

30 January 2023

C. A. Coltman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4521886

30 January 2023

V. Rodriguez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4521886

30 January 2023

E. J. Freireich

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4521886

30 January 2023

language of work or name

English

0 references

publication date

1 March 1974

1 reference

full work available at URL

25 November 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

30 January 2023

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

30 January 2023

1 reference

25 November 2017

volume

33

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

626-630

1 reference

Daunorubicin in the treatment of acute myelocytic leukaemia

25 November 2017

cites work

3

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

Studies on the mechanism of tumor inhibition by L-asparaginase. Effects of the enzyme on asparagine levels in the blood, normal tissues, and 6C3HED lymphomas of mice: differences in asparagine formation and utilization in asparaginase-sensitive and

30 January 2023

4

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

Mechanism of Action of Daunomycin

30 January 2023

5

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

Toxic and antineoplastic effects of L-asparaginase. Study of mice with lymphoma and normal monkeys and report on a child with leukemia.

30 January 2023

9

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

Treatment of adult acute leukemia with arabinosylcytosine and thioguanine

30 January 2023

10

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease

30 January 2023

11

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

Clinical study of daunomycin (NSC-82151) in children with acute leukemia

30 January 2023

12

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

30 January 2023

14

27

2619

Octtgen

1967

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

POMP combination chemotherapy of adult acute leukemia

30 January 2023

15

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

L-asparaginase therapy in children with advanced leukemia. The Southwest Cancer Chemotherapy Study Group

30 January 2023

16

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia

30 January 2023

17

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

30 January 2023

L-asparaginase

18

1 reference

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197403)33:3%3C626::AID-CNCR2820330306%3E3.0.CO;2-5

30 January 2023

Identifiers

10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5

1 reference

25 November 2017

1 reference